One particular challenge in vaccine growth is economic: Many of the diseases most demanding a vaccine, including HIV, malaria and tuberculosis, exist principally in weak international locations. Pharmaceutical companies and biotechnology firms have tiny incentive to develop vaccines for these health conditions because there is little earnings poten